Hepatocellular Carcinoma (HCC): Recent Updates and Evolving Treatment Paradigms - Episode 15

Safety and Efficacy Data From the Retrospective Analysis of the CELESTIAL Study in Advanced HCC

August 22, 2023

R. Katie Kelley, MD, comments on the safety and efficacy data from the retrospective analysis of the CELESTIAL study in advanced hepatocellular carcinoma.

EP. 1: Overview of Hepatocellular Carcinoma (HCC)

EP. 2: Diagnosing Patients With Hepatocellular Carcinoma

EP. 3: Factoring Stage and Hepatic Function Into Treatment Decision-Making for HCC

EP. 4: Treatment Approaches for Patients With Early-Stage HCC

EP. 5: The Role of Adjuvant Therapy in Patients With Early-Stage HCC

EP. 6: Updates in First-Line Systemic Therapy for Advanced HCC: The IMbrave150 Trial

EP. 7: Updates in First-Line Systemic Therapy for Advanced HCC: The HIMALAYA Study

EP. 8: Optimal Sequencing in Patients With Advanced HCC

EP. 9: Safety Profiles of Available Therapies in Advanced HCC

EP. 10: The Future of HCC Treatment

EP. 11: First-Line Systemic Treatment Options for Patients With Advanced HCC

EP. 12: Tremelimumab Plus Durvalumab in Patients With Advanced HCC: The HIMALAYA Study

EP. 13: Key Safety Outcomes From Updated Analysis of HIMALAYA Trial in Advanced HCC

EP. 14: The CELESTIAL Study: Cabozantinib Monotherapy in Advanced HCC Treatment

Now Viewing

EP. 15: Safety and Efficacy Data From the Retrospective Analysis of the CELESTIAL Study in Advanced HCC

EP. 16: Future of Advanced HCC Treatment